GROUDAN v. JANSSEN PHARMACEUTICALS INC et al
GROUDAN and IRIS D. GROUDAN |
JANSSEN PHARMACEUTICALS INC, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT LLC, JANSSEN PHARMACEUTICA INC., JOHNSON & JOHNSON COMPANY, JANSSEN ORTHO LLC, Ortho-McNeil Pharmaceuticals, LLC, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC., JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC, TEVA PHARMACEUTICAL USA, INC., TEVA BRANDED PHARMACEUTICALS PRODUCTS R&D INC, Janssen Pharmaceuticals Inc., Janssen Research and Developement, LLC, ORTHO- MCNEIL-JANSSEN PHARMACEUTICALS, INC. nka JANSSEN PHARMACEUTICALS, INC., Johnson & Johnson Pharmaceutical Research & Development, L.L.C. and TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC |
NJ/2:20-CV-11912 |
August 29, 2020 |
Judicial Panel on Multidistrict Litigation |
Brian R Martinotti |
Other |
Docket Report
This docket was last retrieved on December 16, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 31 OFFICIAL TRANSCRIPT of Hearing held on 12/3/2020 before the Panel at Washington, DC. Court Reporter/Transcriber Bryan Wayne, 333 Constitution Avenue, N.W., Room 4704-A, Washington, DC 20001, bryan_wayne@dcd.uscourts.gov. Transcript may be viewed at the Panel's office or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Redaction due 12/23/2020. Redaction Request due 1/6/2021. Redacted Transcript Deadline set for 1/16/2021. Release of Transcript Restriction set for 3/16/2021.Signed by Clerk of the Panel John W. Nichols on 12/16/2020. Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/3:20-cv-06070, NJ/3:20-cv-07079, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (RH) |
|
Filing 29 SUPPLEMENTAL NOTICE OF HEARING SESSION re: pldg. (15 in ALN/2:20-cv-00993, 19 in CAS/3:20-cv-01266, 16 in FLM/2:20-cv-00330, 12 in FLM/5:20-cv-00390, 12 in FLS/0:20-cv-61721, 20 in FLS/1:20-cv-23144, 19 in FLS/1:20-cv-23380, 12 in FLS/1:20-cv-23500, #102 in MDL No. 2973, 21 in MOW/4:20-cv-00543, 21 in MOW/4:20-cv-00544, 12 in NCM/1:20-cv-00718, 12 in NCM/1:20-cv-00769, 16 in NJ/3:20-cv-06070, 15 in NJ/3:20-cv-07079, 17 in NJ/3:20-cv-07750, 17 in NJ/3:20-cv-07753, 17 in NJ/3:20-cv-07756, 16 in NJ/3:20-cv-07758, 16 in NJ/3:20-cv-08074, 16 in NJ/3:20-cv-09530, 21 in NJ/3:20-cv-10080, 23 in NJ/3:20-cv-10341, 23 in NJ/3:20-cv-10342, 21 in NJ/3:20-cv-10960, 21 in NJ/3:20-cv-10966, 21 in NJ/3:20-cv-10968, 21 in NJ/3:20-cv-11440, 21 in NJ/3:20-cv-11912, 21 in NJ/3:20-cv-11913, 21 in NJ/3:20-cv-11919, 21 in NJ/3:20-cv-11921, 21 in NJ/3:20-cv-12264, 15 in NJ/3:20-cv-12328, 17 in NJ/3:20-cv-12421, 16 in NJ/3:20-cv-12605, 16 in NJ/3:20-cv-12608, 6 in OHN/4:20-cv-01984, 12 in OHS/1:20-cv-00675, 10 in PAE/2:20-cv-02147, 10 in PAE/2:20-cv-02150, 10 in PAE/2:20-cv-02183, 10 in PAE/2:20-cv-02207, 9 in PAE/2:20-cv-02234, 10 in PAE/2:20-cv-02871, 10 in PAE/2:20-cv-03056, 9 in PAE/2:20-cv-03345, 10 in PAE/2:20-cv-04021, 9 in PAE/2:20-cv-04024, 14 in PAE/2:20-cv-04053, 13 in PAE/2:20-cv-04133, 13 in PAE/2:20-cv-04153, 8 in PAE/2:20-cv-04157, 8 in PAE/2:20-cv-04158, 9 in PAE/2:20-cv-04160, 8 in PAE/2:20-cv-04162, 13 in PAE/2:20-cv-04179, 8 in PAE/2:20-cv-04389, 9 in PAE/2:20-cv-04394, 8 in PAE/2:20-cv-04397, 8 in PAE/2:20-cv-04423, 9 in PAE/2:20-cv-04488, 13 in WIE/2:20-cv-01256, 13 in WIE/2:20-cv-01309) Signed by Clerk of the Panel John W. Nichols on 11/16/2020. Associated Cases: MDL No. 2973 et al. (dld) |
Filing 28 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( 1 in MDL No. 2973), ( 102 in MDL No. 2973) Filed by Robert Bruce Hurley, Jr on behalf of Defendants Alza Corporation, #et al.Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals, Inc,, Janssen Ortho LLC, Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., JANSSEN PHARMACEUTICALS, INC., BAYER CORPORATION, BAYER US L.L.C., Centocor Research & Development, Inc. #[Suppress List] (Attachments: #1 Other Parties Represented, #2 Schedule of Actions, #3 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) ADDED MDL LINK Modified on 11/10/2020 (RH). |
Filing 27 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( #64 in MDL No. 2973, 17 in NJ/3:20-cv-10960, 17 in NJ/3:20-cv-10966, 17 in NJ/3:20-cv-10968, 17 in NJ/3:20-cv-11912, 17 in NJ/3:20-cv-11913, 17 in NJ/3:20-cv-11919, 17 in NJ/3:20-cv-11921, 2 in NJ/3:20-cv-13596), ( #102 in MDL No. 2973, 21 in NJ/3:20-cv-10960, 21 in NJ/3:20-cv-10966, 21 in NJ/3:20-cv-10968, 21 in NJ/3:20-cv-11912, 21 in NJ/3:20-cv-11913, 21 in NJ/3:20-cv-11919, 21 in NJ/3:20-cv-11921) Filed by Timothy M. O'Brien on behalf of Plaintiffs MICHELLE L. SCOTT, #et al.MARILYN J EVANS, IRIS D. GROUDAN, DEBORAH F. WEINER, HEATHER E. SHAFFER, MARIA A. RODGERS, RONNA D. YORK, TIFFANY A. KOTZ #[Suppress List] (Attachments: #1 Represented Parties) Associated Cases: MDL No. 2973, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-13596 (O'Brien, Timothy) |
Filing 26 CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( #108 in MDL No. 2973) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS -- Associated Cases: MDL No. 2973 et al. (London, Michael) |
Filing 25 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (17 in ALN/2:20-cv-00993, 21 in CAS/3:20-cv-01266, 18 in FLM/2:20-cv-00330, 13 in FLM/5:20-cv-00390, 13 in FLS/0:20-cv-61721, 3 in FLS/0:20-cv-62068, 23 in FLS/1:20-cv-23144, 21 in FLS/1:20-cv-23380, 13 in FLS/1:20-cv-23500, 5 in ILN/1:20-cv-05989, #108 in MDL No. 2973, 23 in MOW/4:20-cv-00543, 23 in MOW/4:20-cv-00544, 13 in NCM/1:20-cv-00718, 13 in NCM/1:20-cv-00769, 17 in NJ/2:20-cv-07079, 18 in NJ/3:20-cv-06070, 19 in NJ/3:20-cv-07750, 19 in NJ/3:20-cv-07753, 19 in NJ/3:20-cv-07756, 18 in NJ/3:20-cv-07758, 18 in NJ/3:20-cv-08074, 18 in NJ/3:20-cv-09530, 23 in NJ/3:20-cv-10080, 25 in NJ/3:20-cv-10341, 25 in NJ/3:20-cv-10342, 23 in NJ/3:20-cv-10960, 23 in NJ/3:20-cv-10966, 23 in NJ/3:20-cv-10968, 23 in NJ/3:20-cv-11440, 23 in NJ/3:20-cv-11912, 23 in NJ/3:20-cv-11913, 23 in NJ/3:20-cv-11919, 23 in NJ/3:20-cv-11921, 23 in NJ/3:20-cv-12264, 17 in NJ/3:20-cv-12328, 18 in NJ/3:20-cv-12421, 7 in NJ/3:20-cv-12547, 18 in NJ/3:20-cv-12605, 18 in NJ/3:20-cv-12608, 10 in NJ/3:20-cv-13596, 7 in NJ/3:20-cv-13940, 5 in NJ/3:20-cv-14439, 3 in NJ/3:20-cv-14447, 3 in NJ/3:20-cv-14448, 3 in NJ/3:20-cv-14450, 3 in NJ/3:20-cv-14452, 3 in NJ/3:20-cv-14663, 3 in NJ/3:20-cv-14668, 3 in NJ/3:20-cv-14670, 7 in OHN/4:20-cv-01984, 13 in OHS/1:20-cv-00675, 4 in OHS/1:20-cv-00755, 11 in PAE/2:20-cv-02147, 11 in PAE/2:20-cv-02150, 11 in PAE/2:20-cv-02183, 11 in PAE/2:20-cv-02207, 10 in PAE/2:20-cv-02234, 11 in PAE/2:20-cv-02871, 11 in PAE/2:20-cv-03056, 10 in PAE/2:20-cv-03345, 11 in PAE/2:20-cv-04021, 10 in PAE/2:20-cv-04024, 15 in PAE/2:20-cv-04053, 14 in PAE/2:20-cv-04133, 14 in PAE/2:20-cv-04153, 9 in PAE/2:20-cv-04157, 9 in PAE/2:20-cv-04158, 10 in PAE/2:20-cv-04160, 9 in PAE/2:20-cv-04162, 14 in PAE/2:20-cv-04179, 9 in PAE/2:20-cv-04389, 10 in PAE/2:20-cv-04394, 9 in PAE/2:20-cv-04397, 9 in PAE/2:20-cv-04423, 10 in PAE/2:20-cv-04488, 7 in PAE/2:20-cv-04726, 4 in PAE/2:20-cv-04773, 4 in PAE/2:20-cv-04775, 4 in PAE/2:20-cv-04777, 4 in PAE/2:20-cv-04778, 4 in PAE/2:20-cv-04779, 4 in PAE/2:20-cv-04787, 4 in PAE/2:20-cv-04788, 4 in PAE/2:20-cv-04789, 4 in PAE/2:20-cv-04790, 4 in PAE/2:20-cv-04791, 4 in PAE/2:20-cv-04929, 3 in PAE/2:20-cv-04936, 3 in PAE/2:20-cv-04945, 14 in WIE/2:20-cv-01256, 14 in WIE/2:20-cv-01309) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS -- Associated Cases: MDL No. 2973 et al. (London, Michael) |
Filing 24 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #4 in MDL No. 2973), ( #10 in MDL No. 2973), ( #1 in MDL No. 2973) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Panel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel John W. Nichols on 10/23/2020. Associated Cases: MDL No. 2973 et al. (TF) |
Filing 23 REPLY TO RESPONSE TO MOTION FOR TRANSFER re: pldg. ( #1 in MDL No. 2973) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2973 et al. (London, Michael) |
Filing 22 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (8 in ALN/2:20-cv-00993, 37 in MDL No. 2973, 8 in NJ/3:20-cv-09530, 10 in NJ/3:20-cv-10960, 10 in NJ/3:20-cv-10966, 10 in NJ/3:20-cv-10968, 10 in NJ/3:20-cv-11912, 10 in NJ/3:20-cv-11913, 10 in NJ/3:20-cv-11919, 10 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12328), (5 in ALN/2:20-cv-00993, 7 in CAS/3:20-cv-01266, 7 in FLS/1:20-cv-23144, 8 in FLS/1:20-cv-23380, 31 in MDL No. 2973, 7 in MOW/4:20-cv-00543, 7 in MOW/4:20-cv-00544, 7 in NJ/3:20-cv-07750, 7 in NJ/3:20-cv-07753, 7 in NJ/3:20-cv-07756, 7 in NJ/3:20-cv-07758, 7 in NJ/3:20-cv-08074, 5 in NJ/3:20-cv-09530, 6 in NJ/3:20-cv-10080, 7 in NJ/3:20-cv-10341, 7 in NJ/3:20-cv-10342, 5 in NJ/3:20-cv-10960, 5 in NJ/3:20-cv-10966, 5 in NJ/3:20-cv-10968, 5 in NJ/3:20-cv-11912, 5 in NJ/3:20-cv-11913, 5 in NJ/3:20-cv-11919, 5 in NJ/3:20-cv-11921, 6 in NJ/3:20-cv-12264, 5 in NJ/3:20-cv-12328, 7 in NJ/3:20-cv-12605, 7 in NJ/3:20-cv-12608), (7 in ALN/2:20-cv-00993, 10 in FLS/1:20-cv-23144, 34 in MDL No. 2973, 9 in NJ/3:20-cv-07750, 9 in NJ/3:20-cv-07753, 9 in NJ/3:20-cv-07756, 9 in NJ/3:20-cv-07758, 9 in NJ/3:20-cv-08074, 7 in NJ/3:20-cv-09530, 8 in NJ/3:20-cv-10080, 9 in NJ/3:20-cv-10341, 9 in NJ/3:20-cv-10342, 7 in NJ/3:20-cv-10960, 7 in NJ/3:20-cv-10966, 7 in NJ/3:20-cv-10968, 7 in NJ/3:20-cv-11912, 7 in NJ/3:20-cv-11913, 7 in NJ/3:20-cv-11919, 7 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12264, 7 in NJ/3:20-cv-12328, 9 in NJ/3:20-cv-12605, 9 in NJ/3:20-cv-12608), (11 in CAS/3:20-cv-01266, 41 in MDL No. 2973), ( 39 in MDL No. 2973, 10 in MOW/4:20-cv-00543, 10 in MOW/4:20-cv-00544)( 56 in MDL No. 2973) Filed by Defendants Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., IVAX LLC, Baker Norton U.S., Inc., and Baker Norton Pharmaceuticals, Inc. -- Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/22/2020 (TF). REMOVED DUPLICATE PARTIES. ADDED MDL LINK. |
|
Filing 20 RESPONSE -- (re: pldg. ( 1 in MDL No. 2973) ) Filed by Defendants Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., IVAX LLC, Baker Norton U.S., Inc., and Baker Norton Pharmaceuticals, Inc. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/16/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 19 RESPONSE -- (re: pldg. ( 1 in MDL No. 2973) ) Filed by Defendant JANSSEN PHARMACEUTICALS, INC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/16/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 18 CERTIFICATE OF SERVICE re: pldg. ( #63 in MDL No. 2973, 16 in NJ/3:20-cv-10960, 16 in NJ/3:20-cv-10966, 16 in NJ/3:20-cv-10968, 16 in NJ/3:20-cv-11912, 16 in NJ/3:20-cv-11913, 16 in NJ/3:20-cv-11919, 16 in NJ/3:20-cv-11921, 1 in NJ/3:20-cv-13596), ( #64 in MDL No. 2973, 17 in NJ/3:20-cv-10960, 17 in NJ/3:20-cv-10966, 17 in NJ/3:20-cv-10968, 17 in NJ/3:20-cv-11912, 17 in NJ/3:20-cv-11913, 17 in NJ/3:20-cv-11919, 17 in NJ/3:20-cv-11921, 2 in NJ/3:20-cv-13596) Filed by Plaintiffs MICHELLE L. SCOTT, #et al.MARILYN J EVANS, IRIS D. GROUDAN, DEBORAH F. WEINER, HEATHER E. SHAFFER, MARIA A. RODGERS, RONNA D. YORK, TIFFANY A. KOTZ #[Suppress List] -- Associated Cases: MDL No. 2973, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-13596 (O'Brien, Timothy) |
Filing 17 RESPONSE IN SUPPORT WITH INTERESTED PARTIES -- (re: pldg. ( 1 in MDL No. 2973), ( #10 in MDL No. 2973)( #4 in MDL No. 2973) ) Filed by Plaintiffs MICHELLE SCOTT, DEBORAH WEINER, RONNA YORK, MARILYN EVANS, IRIS GROUDAN, TIFFANY KOTZ, MARIA RODGERS, AND HEATHER SHAFFER. (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2973, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-13596 (O'Brien, Timothy) Modified on 10/14/2020 (TF) ADDED MDL LINK. ADDED PARTY NAMES. |
Filing 16 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( #4 in MDL No. 2973), ( #10 in MDL No. 2973), ( 1 in MDL No. 2973)( 35 in MDL No. 2973) Filed by Timothy M. O'Brien on behalf of Plaintiffs MICHELLE L. SCOTT, #et al.MARILYN J EVANS, IRIS D. GROUDAN, DEBORAH F. WEINER, HEATHER E. SHAFFER, MARIA A. RODGERS, RONNA D. YORK, TIFFANY A. KOTZ #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2973, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-13596 (O'Brien, Timothy) Modified on 10/14/2020 (TF) ADDED MDL LINK. |
Filing 15 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (8 in ALN/2:20-cv-00993, 37 in MDL No. 2973, 8 in NJ/3:20-cv-09530, 10 in NJ/3:20-cv-10960, 10 in NJ/3:20-cv-10966, 10 in NJ/3:20-cv-10968, 10 in NJ/3:20-cv-11912, 10 in NJ/3:20-cv-11913, 10 in NJ/3:20-cv-11919, 10 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12328), (5 in ALN/2:20-cv-00993, 7 in CAS/3:20-cv-01266, 7 in FLS/1:20-cv-23144, 8 in FLS/1:20-cv-23380, 31 in MDL No. 2973, 7 in MOW/4:20-cv-00543, 7 in MOW/4:20-cv-00544, 7 in NJ/3:20-cv-07750, 7 in NJ/3:20-cv-07753, 7 in NJ/3:20-cv-07756, 7 in NJ/3:20-cv-07758, 7 in NJ/3:20-cv-08074, 5 in NJ/3:20-cv-09530, 6 in NJ/3:20-cv-10080, 7 in NJ/3:20-cv-10341, 7 in NJ/3:20-cv-10342, 5 in NJ/3:20-cv-10960, 5 in NJ/3:20-cv-10966, 5 in NJ/3:20-cv-10968, 5 in NJ/3:20-cv-11912, 5 in NJ/3:20-cv-11913, 5 in NJ/3:20-cv-11919, 5 in NJ/3:20-cv-11921, 6 in NJ/3:20-cv-12264, 5 in NJ/3:20-cv-12328, 7 in NJ/3:20-cv-12605, 7 in NJ/3:20-cv-12608), (7 in ALN/2:20-cv-00993, 10 in FLS/1:20-cv-23144, 34 in MDL No. 2973, 9 in NJ/3:20-cv-07750, 9 in NJ/3:20-cv-07753, 9 in NJ/3:20-cv-07756, 9 in NJ/3:20-cv-07758, 9 in NJ/3:20-cv-08074, 7 in NJ/3:20-cv-09530, 8 in NJ/3:20-cv-10080, 9 in NJ/3:20-cv-10341, 9 in NJ/3:20-cv-10342, 7 in NJ/3:20-cv-10960, 7 in NJ/3:20-cv-10966, 7 in NJ/3:20-cv-10968, 7 in NJ/3:20-cv-11912, 7 in NJ/3:20-cv-11913, 7 in NJ/3:20-cv-11919, 7 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12264, 7 in NJ/3:20-cv-12328, 9 in NJ/3:20-cv-12605, 9 in NJ/3:20-cv-12608), (11 in CAS/3:20-cv-01266, 41 in MDL No. 2973), ( 39 in MDL No. 2973, 10 in MOW/4:20-cv-00543, 10 in MOW/4:20-cv-00544) Filed by Defendants TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., TEVA PHARMACEUTICALS USA, INC., IVAX LLC, BAKER NORTON PHARMACEUTICALS, BAKER NORTON U.S., INC. -- Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/13/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 14 CERTIFICATE OF SERVICE re: pldg. ( #36 in MDL No. 2973, 9 in NJ/3:20-cv-10960, 9 in NJ/3:20-cv-10966, 9 in NJ/3:20-cv-10968, 9 in NJ/3:20-cv-11912, 9 in NJ/3:20-cv-11913, 9 in NJ/3:20-cv-11919, 9 in NJ/3:20-cv-11921), ( #35 in MDL No. 2973, 8 in NJ/3:20-cv-10960, 8 in NJ/3:20-cv-10966, 8 in NJ/3:20-cv-10968, 8 in NJ/3:20-cv-11912, 8 in NJ/3:20-cv-11913, 8 in NJ/3:20-cv-11919, 8 in NJ/3:20-cv-11921) Filed by Plaintiffs MICHELLE L. SCOTT, #et al.MARILYN J EVANS, IRIS D. GROUDAN, HEATHER E. SHAFFER, MARIA A. RODGERS, TIFFANY A. KOTZ, RONNA D. YORK #[Suppress List] -- Associated Cases: MDL No. 2973, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921 (O'Brien, Timothy) |
Filing 13 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Johnson & Johnson for ORTHO -MCNEIL PHARMACEUTICAL, INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 12 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent No Parent Corp. for JOHNSON & JOHNSON. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 11 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Centocor Research & Development, Inc. for JANSSEN RESEARCH & DEVELOPMENT LLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 10 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for TEVA PHARMACEUTICAL USA, INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, NJ/3:20-cv-09530, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12328 (McIntosh, Thomas) Modified on 10/13/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 9 SEE CORRECTED PLEADING 64 IN MDL 2973 RESPONSE IN SUPPORT -- (re: pldg. ( #4 in MDL No. 2973), ( 1 in MDL No. 2973), ( #10 in MDL No. 2973) ) Filed by Plaintiffs MICHELLE L. SCOTT, #et al.MARILYN J EVANS, IRIS D. GROUDAN, HEATHER E. SHAFFER, MARIA A. RODGERS, TIFFANY A. KOTZ, RONNA D. YORK #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2973, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921 (O'Brien, Timothy) Modified on 10/14/2020 (TF). |
Filing 8 SEE CORRECTED PLEADING 63 IN MDL 2973 NOTICE OF APPEARANCE re: pldg.( #4 in MDL No. 2973), ( #10 in MDL No. 2973), ( 1 in MDL No. 2973) Filed by Timothy M. O'Brien on behalf of Plaintiffs MICHELLE L. SCOTT, #et al.MARILYN J EVANS, IRIS D. GROUDAN, HEATHER E. SHAFFER, MARIA A. RODGERS, TIFFANY A. KOTZ, RONNA D. YORK #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 2973, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921 (O'Brien, Timothy) Modified on 10/9/2020 (TF). MODIFIED ATTACHMENT DESCRIPTION |
Filing 7 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, FLS/1:20-cv-23144, NJ/3:20-cv-06070, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12605, NJ/3:20-cv-12608 (McIntosh, Thomas) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Johnson & Johnson for JANSSEN PHARMACEUTICALS INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 5 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 2973) Filed by Thomas G McIntosh on behalf of Defendants TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., TEVA PHARMACEUTICALS USA, INC., IVAX LLC, BAKER NORTON PHARMACEUTICALS, BAKER NORTON U.S., INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 4 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent OMJ PR Holdings for JANSSEN ORTHO LLC. Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 3 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 2973) Filed by Robert Bruce Hurley, Jr on behalf of Defendants ALZA CORPORATION, CENTOCOR RESEARCH & DEVELOPMENT, INC., JANSSEN ORTHO LLC, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT LLC, ORTHO-MCNEIL PHARMACEUTICALS, INC., JOHNSON & JOHNSON, BAYER CORPORATION, BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., AND BAYER US LLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES. |
Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 2973) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 10/8/2020. Corporate Disclosure Statements due on or before 10/8/2020. Responses due on or before 10/15/2020. Reply, if any, due on or before 10/22/2020. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 9/24/2020. Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/2:20-cv-07079, NJ/3:20-cv-06070, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (LH) |
Filing 1 MDL Number 2973 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 135) Associated Cases: Pending No. 135, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/2:20-cv-07079, NJ/3:20-cv-06070, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (LH) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.